BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 28102174)

  • 1. Modeling dynamics of mutants in heterogeneous stem cell niche.
    Shahriyari L; Mahdipour-Shirayeh A
    Phys Biol; 2017 Feb; 14(1):016004. PubMed ID: 28102174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant Asymmetrical Stem Cell Fate Outcome Limits the Rate of Niche Succession in Human Colonic Crypts.
    Stamp C; Zupanic A; Sachdeva A; Stoll EA; Shanley DP; Mathers JC; Kirkwood TBL; Heer R; Simons BD; Turnbull DM; Greaves LC
    EBioMedicine; 2018 May; 31():166-173. PubMed ID: 29748033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Articulating the "stem cell niche" paradigm through the lens of non-model aquatic invertebrates.
    Martinez P; Ballarin L; Ereskovsky AV; Gazave E; Hobmayer B; Manni L; Rottinger E; Sprecher SG; Tiozzo S; Varela-Coelho A; Rinkevich B
    BMC Biol; 2022 Jan; 20(1):23. PubMed ID: 35057814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical model of cancer stem cell driven tumor initiation: implications of niche size and loss of homeostatic regulatory mechanisms.
    Gentry SN; Jackson TL
    PLoS One; 2013; 8(8):e71128. PubMed ID: 23990931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A theory of evolutionary dynamics on any complex population structure reveals stem cell niche architecture as a spatial suppressor of selection.
    Kuo YP; Nombela-Arrieta C; Carja O
    Nat Commun; 2024 May; 15(1):4666. PubMed ID: 38821923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-organ Mapping of Cancer Risk.
    Zhu L; Finkelstein D; Gao C; Shi L; Wang Y; López-Terrada D; Wang K; Utley S; Pounds S; Neale G; Ellison D; Onar-Thomas A; Gilbertson RJ
    Cell; 2016 Aug; 166(5):1132-1146.e7. PubMed ID: 27565343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell mutations, associated cancer risk, and consequences for regenerative medicine.
    Derks LLM; van Boxtel R
    Cell Stem Cell; 2023 Nov; 30(11):1421-1433. PubMed ID: 37832550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic evolutionary models in stem cell biology: replacement, quiescence, and variability.
    Mangel M; Bonsall MB
    PLoS One; 2008 Feb; 3(2):e1591. PubMed ID: 18270578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX9-positive pituitary stem cells differ according to their position in the gland and maintenance of their progeny depends on context.
    Rizzoti K; Chakravarty P; Sheridan D; Lovell-Badge R
    Sci Adv; 2023 Oct; 9(40):eadf6911. PubMed ID: 37792947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic modeling of stem-cell dynamics with control.
    Sun Z; Komarova NL
    Math Biosci; 2012 Dec; 240(2):231-40. PubMed ID: 22960597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bio-Mechanical Model of Osteosarcoma Tumor Microenvironment: A Porous Media Approach.
    Hu Y; Mohammad Mirzaei N; Shahriyari L
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice.
    Mohammad Mirzaei N; Tatarova Z; Hao W; Changizi N; Asadpoure A; Zervantonakis IK; Hu Y; Chang YH; Shahriyari L
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model.
    Mohammad Mirzaei N; Changizi N; Asadpoure A; Su S; Sofia D; Tatarova Z; Zervantonakis IK; Chang YH; Shahriyari L
    PLoS Comput Biol; 2022 Mar; 18(3):e1009953. PubMed ID: 35294447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration.
    Mohammad Mirzaei N; Su S; Sofia D; Hegarty M; Abdel-Rahman MH; Asadpoure A; Cebulla CM; Chang YH; Hao W; Jackson PR; Lee AV; Stover DG; Tatarova Z; Zervantonakis IK; Shahriyari L
    J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model.
    Le T; Su S; Shahriyari L
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer.
    Budithi A; Su S; Kirshtein A; Shahriyari L
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data-Driven Mathematical Model of Osteosarcoma.
    Le T; Su S; Kirshtein A; Shahriyari L
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data Driven Mathematical Model of Colon Cancer Progression.
    Kirshtein A; Akbarinejad S; Hao W; Le T; Su S; Aronow RA; Shahriyari L
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33291412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic heterogeneity in modeling cancer evolution.
    Mahdipour-Shirayeh A; Kaveh K; Kohandel M; Sivaloganathan S
    PLoS One; 2017; 12(10):e0187000. PubMed ID: 29084232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of backward cell migration in two-hit mutants' production in the stem cell niche.
    Bollas A; Shahriyari L
    PLoS One; 2017; 12(9):e0184651. PubMed ID: 28931019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.